MedTrace Logo

CGM-Based Glycemic Analysis After ESI

NCT07280780 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2026-04-09

No results posted yet for this study

Summary

The goal of this clinical study is to learn how blood glucose levels change after an epidural steroid injection (ESI) with dexamethasone in adults. It will specifically compare the glycemic response between patients with type 2 diabetes and those without diabetes.

The main questions it aims to answer are:

Does the injection cause higher or longer-lasting blood glucose elevation in diabetic patients compared to non-diabetic patients? How do the mean glucose level and Time in Range (TIR) change after the injection in both groups?

Researchers will compare a Type 2 Diabetes group to a Non-Diabetes group to see the differences in glycemic fluctuations using a continuous glucose monitoring (CGM) device.

Participants will:

* Wear a small CGM sensor on their arm for about 15 days to monitor blood glucose levels continuously
* Receive an epidural steroid injection containing 5 mg of dexamethasone on Day 3
* Visit the clinic 3 times (Day 1, Day 3, and Day 15) for sensor attachment, the injection procedure, and data collection

Conditions

  • Type 2 Diabetes (T2DM)
  • Hyperglycemia
  • Radicular Pain
  • Spinal Stenosis
  • Intervertebral Disc Herniation

Interventions

PROCEDURE

Epidural Steroid Injection

Administration of 5 mg Dexamethasone via epidural route (cervical or lumbar) under fluoroscopic guidance.

DEVICE

Continuous Glucose Monitoring

A sensor attached to the upper arm to monitor interstitial glucose levels continuously for 15 days.

Sponsors & Collaborators

  • The Korean Pain Society

    collaborator UNKNOWN

  • Korea University Anam Hospital

    lead OTHER

Principal Investigators

  • Sunmin Kim, M.D. · Korea University Anam Hospital

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-20
Primary Completion
2026-12-20
Completion
2026-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07280780 on ClinicalTrials.gov